Metraipolis › archive › dc_37bee6d79908

Hospitalisation Is a Strong Risk Factor for Discontinuation of Sodium-Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes — Europe PMC PMID:42608294

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42608294
DOI
10.1111/dom.71219
License (as archived)
solo-consultazione
Archived
2026-10-17T10:02:09.659Z
SHA-256 of the archived text
4bfb43c7ed3b5388b483f1df38200e850706ec91ce3d72bcc3835c685f7c9974
Stable URL of this page
https://metraipolis.com/documento/dc_37bee6d79908

How to cite

Hospitalisation Is a Strong Risk Factor for Discontinuation of Sodium-Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes — Europe PMC PMID:42608294 — Europe PMC (en), https://europepmc.org/article/MED/42608294 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_37bee6d79908 (Metraipolis archive dc_37bee6d79908, sha256 4bfb43c7ed3b5388b483f1df38200e850706ec91ce3d72bcc3835c685f7c9974)
BibTeX
@misc{dc37bee6d79908,
  title = {Hospitalisation Is a Strong Risk Factor for Discontinuation of Sodium-Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes — Europe PMC PMID:42608294},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42608294},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_37bee6d79908; sha256 4bfb43c7ed3b5388b483f1df38200e850706ec91ce3d72bcc3835c685f7c9974},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42608294. Agents can read the archived copy with the MCP tool read_document.